These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30360549)

  • 1. Sterically Stabilized RIPL Peptide-Conjugated Nanostructured Lipid Carriers: Characterization, Cellular Uptake, Cytotoxicity, and Biodistribution.
    Kim CH; Sung SW; Lee ES; Kang TH; Yoon HY; Goo YT; Cho HR; Kim DY; Kang MJ; Choi YS; Lee S; Choi YW
    Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30360549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells.
    Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW
    Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation.
    Kim CH; Sa CK; Goh MS; Lee ES; Kang TH; Yoon HY; Battogtokh G; Ko YT; Choi YW
    Int J Nanomedicine; 2018; 13():6661-6675. PubMed ID: 30425481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
    Lee SG; Kim CH; Sung SW; Lee ES; Goh MS; Yoon HY; Kang MJ; Lee S; Choi YW
    Int J Nanomedicine; 2018; 13():3263-3278. PubMed ID: 29910614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface-Modification of RIPL Peptide-Conjugated Liposomes to Achieve Steric Stabilization and pH Sensitivity.
    Kwon YH; Shin TH; Jang MH; Yoon HY; Kang MH; Kang MJ; Choi YW
    J Nanosci Nanotechnol; 2017 Feb; 17(2):1008-17. PubMed ID: 29671978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel-loaded RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes: Drug release, cytotoxicity, and antitumor efficacy.
    Yoon HY; Kwak SS; Jang MH; Kang MH; Sung SW; Kim CH; Kim SR; Yeom DW; Kang MJ; Choi YW
    Int J Pharm; 2017 May; 523(1):229-237. PubMed ID: 28341149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity.
    Safwat S; Ishak RAH; Hathout RM; Mortada ND
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1112-1125. PubMed ID: 28276784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
    Kang MH; Park MJ; Yoo HJ; hyuk KY; Lee SG; Kim SR; Yeom DW; Kang MJ; Choi YW
    Eur J Pharm Biopharm; 2014 Aug; 87(3):489-99. PubMed ID: 24704199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.
    Zhang X; Gan Y; Gan L; Nie S; Pan W
    J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
    J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation.
    Yue Y; Zhao D; Yin Q
    Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalized Lipid Nanocarriers for Simultaneous Delivery of Docetaxel and Tariquidar to Chemoresistant Cancer Cells.
    Kim CH; Lee S; Choi JY; Lyu MJ; Jung HM; Goo YT; Kang MJ; Choi YW
    Pharmaceuticals (Basel); 2023 Feb; 16(3):. PubMed ID: 36986449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells.
    Varshosaz J; Davoudi MA; Rasoul-Amini S
    J Liposome Res; 2018 Dec; 28(4):285-295. PubMed ID: 28826287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer.
    Yang Y; Qiu D; Liu Y; Chao L
    Drug Des Devel Ther; 2019; 13():3307-3319. PubMed ID: 31571832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy.
    Zhang G; Liu F; Jia E; Jia L; Zhang Y
    Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Formulation of Paromomycin Sulphate as a Promising Fucose-Conjugated Nanostructured Lipid Carrier for Antileishmanial Drug Delivery.
    Chowdhary SJ; Chowdhary A; Agrawal GP; Jain A
    ACS Biomater Sci Eng; 2021 Jan; 7(1):157-165. PubMed ID: 33350804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-Drug Nanosystem: Etoposide Prodrug and Cisplatin Coloaded Nanostructured Lipid Carriers for Lung Cancer Therapy.
    Du M; Yin J
    Drug Des Devel Ther; 2022; 16():4139-4149. PubMed ID: 36506793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy.
    Song S; Mao G; Du J; Zhu X
    Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
    Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D
    Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
    Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
    Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.